Compare
Inspire Medical Systems, Inc. vs Orthofix Medical Inc. vs Tandem Diabetes Care Inc vs Embecta Corp.
| Latest fiscal year | Inspire Medical Systems, Inc. INSP | Orthofix Medical Inc. OFIX | Tandem Diabetes Care Inc TNDM | Embecta Corp. EMBC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $911.98M | $822.31M | $1.01B | $1.08B |
| Revenue growth (YoY) | +13.6% | +2.9% | +7.9% | -3.8% |
| Gross margin | 85.4% | 68.8% | 53.8% | 62.6% |
| Operating margin | 5.6% | -9.9% | -18.5% | 22.4% |
| Net margin | 15.9% | -11.2% | -20.2% | 8.8% |
| Net income | $145.42M | -$92.19M | -$204.71M | $95.40M |
| EPS (Diluted) | $4.89 | -$2.33 | -$3.04 | $1.62 |
| Operating cash flow | $116.98M | $33.35M | -$9.72M | $191.70M |
| Free cash flow | $78.48M | -$1.28M | -$29.67M | $182.40M |
| Cash & equivalents | $104.81M | $82.03M | $90.63M | $225.50M |
| Total assets | $907.32M | $850.65M | $881.11M | $1.09B |
| Total liabilities | $126.16M | $400.61M | $725.94M | n/a |
| Shareholders' equity | $781.16M | $450.04M | $155.17M | -$650.60M |
| Return on year-end equity | 18.6% | -20.5% | -131.9% | n/a |
| Shares outstanding | 28.58M | 39.83M | 68.29M | 58.50M |
Revenue, most recent five fiscal years
| Fiscal year | Inspire Medical Systems, Inc. | Orthofix Medical Inc. | Tandem Diabetes Care Inc | Embecta Corp. |
|---|---|---|---|---|
| Latest | $911.98M Ended 2025-12-31 | $822.31M Ended 2025-12-31 | $1.01B Ended 2025-12-31 | $1.08B Ended 2025-09-30 |
| 1 year earlier | $802.80M Ended 2024-12-31 | $799.49M Ended 2024-12-31 | $940.20M Ended 2024-12-31 | $1.12B Ended 2024-09-30 |
| 2 years earlier | $624.80M Ended 2023-12-31 | $746.64M Ended 2023-12-31 | $747.72M Ended 2023-12-31 | $1.12B Ended 2023-09-30 |
| 3 years earlier | $407.86M Ended 2022-12-31 | $460.71M Ended 2022-12-31 | $801.22M Ended 2022-12-31 | $1.13B Ended 2022-09-30 |
| 4 years earlier | $233.39M Ended 2021-12-31 | $464.48M Ended 2021-12-31 | $702.80M Ended 2021-12-31 | $1.17B Ended 2021-09-30 |